Since 2002, Medtronic and a group of doctors with financial ties to the medical device company were aware that a new biological agent used in back surgery was linked to sterility in men. But that crucial information was not revealed in medical journal articles written by those doctors, including surgeons who would receive millions of dollars in various royalties from Medtronic.
Researchers get royalties, papers omit sterility link
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.